MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The comparison of cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease

SJ. Kim, EJ. Chung (Busan, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 1690

Keywords: Cognitive dysfunction

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: The aim is to compare the cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease (PD).

Background: PD with mild cognitive impairment (PD-MCI) patients exhibited reduced FDG uptake in the parietal and occipital lobes and in localized areas of the frontal and temporal lobes compared with controls, whereas PD with dementia (PDD) showed a widespread reduction of cortical metabolism.

Method: Twenty seven PD patients performed the FDG-PET. Nine patients showed normal FDG-PET. Eighteen patients showed abnormal hypometabolism. Cognitive function of PD were evaluated by using three brief screening tools such as mini-mental state examination (MMSE), Montreal Cognitive Assessment (MoCA) and Frontal assessment battery (FAB).

Results: Hypometabolism was revealed in the parietooccipitotemporal lobes, caudate nucleus and medial frontal lobes, and thalamus. PD patients with hypometabolism showed statistically significant lower scores in MMSE (p = 0.02), MoCA (p = 0.0245) and FAB (p = 0.0427) compared to those of PD with normal FDG-PET. In subitems analysis, a language of MMSE (p = 0.0201) and MoCA (p = 0.0252), an orientation of MMSE (p = 0.0426), and a memory of MoCA (p = 0.0371) showed significant differences between PD with normal and abnormal metabolism.

Conclusion: Like previously established reports, PD patients with hypometabolism showed more severe cognitive impairment than PD with normal metabolism. Language and memory including orientation domains in both MMSE and MoCA showed significantly low score. Contrast to MoCA and MMSE, any subitems of FAB did not showed significant differences between 2 groups. This point showed the limitation of the FAB as a screening assessment in the cognitive function of PD.

To cite this abstract in AMA style:

SJ. Kim, EJ. Chung. The comparison of cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/the-comparison-of-cognitive-function-between-normal-and-abnormal-fdg-pet-in-non-demented-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-comparison-of-cognitive-function-between-normal-and-abnormal-fdg-pet-in-non-demented-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley